Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Income from Continuing Operations (2023 - 2025)

Historic Income from Continuing Operations for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$55.8 million.

  • Nuvation Bio's Income from Continuing Operations fell 3538.46% to -$55.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$217.5 million, marking a year-over-year increase of 5914.19%. This contributed to the annual value of -$567.9 million for FY2024, which is 64924.01% down from last year.
  • Per Nuvation Bio's latest filing, its Income from Continuing Operations stood at -$55.8 million for Q3 2025, which was down 3538.46% from -$59.0 million recorded in Q2 2025.
  • Over the past 5 years, Nuvation Bio's Income from Continuing Operations peaked at -$13.8 million during Q4 2023, and registered a low of -$462.5 million during Q2 2024.
  • Moreover, its 3-year median value for Income from Continuing Operations was -$41.2 million (2024), whereas its average is -$73.8 million.
  • Per our database at Business Quant, Nuvation Bio's Income from Continuing Operations crashed by 214075.58% in 2024 and then soared by 8724.15% in 2025.
  • Nuvation Bio's Income from Continuing Operations (Quarter) stood at -$13.8 million in 2023, then tumbled by 258.63% to -$49.4 million in 2024, then decreased by 12.84% to -$55.8 million in 2025.
  • Its Income from Continuing Operations was -$55.8 million in Q3 2025, compared to -$59.0 million in Q2 2025 and -$53.2 million in Q1 2025.